Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Done., Patient Advocates, and Stakeholders Call For Vital Patient Access To Telehealth


News provided by

Done.

Oct 20, 2022, 10:00 ET

Share this article

Share toX

Share this article

Share toX


Lack of action by DEA could replace one public health emergency with another

WASHINGTON, Oct. 20, 2022 /PRNewswire-PRWeb/ -- The founder of Done. Global Inc., a leading telehealth provider of services for people with attention-deficit/hyperactivity disorder (ADHD), joined renowned medical experts, patients, and a former member of Congress during a policy briefing to advocate for regulatory relief that would permanently allow some clinicians to prescribe medications online without the need to meet in person.

The "special registration" designation, a provision for providers seeking to prescribe controlled substances via telehealth, falls under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 and has yet to be effectuated by the Drug Enforcement Administration (DEA) through the promulgation of implementing regulations. Generally, to prescribe controlled substances via telehealth a provider has to first have had an in-person encounter with the patient. However, the in-person requirement has been suspended during the declared federal Public Health Emergency but could be changed at any time. After 14 years of inaction, DEA submitted a draft regulation to the White House Office of Management and Budget on March 17, 2022, and no action has yet to be taken.

...As Americans and providers continue to see the benefits of telehealth, we are pleased to participate in this discussion about the vital role that platforms like Done have played in bridging gaps in access to high-quality care for patients across the United States...

Post this

The briefing panelists included former Rep. Bart Stupak (D-Mich.), who represented Michigan's 1st District from 1993-2011 and is now a Partner at Venable LLP; two congressional staffers; Dr. Zoe Martinez, Clinical Director for Done Health P.C. and board-certified psychiatrist from UCLA who previously worked at institutions like Kaiser Permanente; and the Founder of Done. Global Inc., Ruthia He.

"With more than 17 million people with ADHD in the U.S. and less than 30,000 psychiatrists to treat them, we hope to bridge the gap by providing a patient-first, technology-powered ADHD management platform that connects patients with psychiatric board-certified clinicians for services, including clinical consultations, chronic care management, and 24/7 care team support," said He during her opening remarks. "As Americans and providers continue to see the benefits of telehealth, we are pleased to participate in this discussion about the vital role that platforms like Done have played in bridging gaps in access to high-quality care for patients across the United States. However, it would be disheartening to see that these patients we have helped would not be able to continue their care after the PHE [public health emergency] expires."

The ability to prescribe medications without seeing someone in person is particularly critical for people living in remote parts of the country where medical access is difficult or even non-existent and for anyone who lives with physical disabilities or additional diseases, disorders, or behaviors that make it virtually impossible to leave their home and travel to a medical facility. He and others also referenced the fact that adults with ADHD are five times more likely to die by suicide in the absence of proper treatment.

"Telehealth has been groundbreaking for many patients who do not have easy access to doctors, never mind specialty providers," said Dr. Martinez. "COVID may have provided a reason to loosen some restrictions, but the need for increased access was there long before that particular health crisis."

Participants in the briefing also referenced a letter from May 2022 addressed to Anne Milgram, DEA Administrator, and signed by the bipartisan leaders of the Health, Communications & Technology, and Consumer Protection & Commerce Subcommittees of the House Energy and Commerce Committee. The letter implores the DEA to develop the requisite framework for designation of "special registration" and deems its inaction "unacceptable."

Done. executives will also submit a letter to President Joe Biden to request immediate attention on this issue and present findings and testimonials from patients – in-person – that underscored the pressing need for the DEA to take action.

Silvia S., who works in healthcare, in her remarks at the briefing shared her experience with how difficult it is to find ADHD treatment. And Dave W., a working professional and briefing panelist, said that he struggled to find adult ADHD care in his state. When he learned that his daughter also has ADHD he described much of the medical advice they received as subpar before discovering Done.

Throughout its existence, Done. has adhered to stringent standards to ensure the safety of patients. Before seeing a clinician, all patients must complete screenings for current controlled substance use and clinically significant depression and/or anxiety. It is crucial for the potential patient to go on to the initial assessment by a board-certified or eligible psychiatrist or psychiatric mental health board-certified nurse practitioner.

If that clinician decides the potential patient can benefit from treatment, the clinician will prepare a treatment plan and may issue prescriptions (enough for 30 days) in accordance with state/federal regulations. Throughout their treatment, patients complete symptom reports and health tracking and go through regular monthly check-ins on the platform.

October is ADHD Awareness Month – the same month in which World Mental Health Day takes place. The message at this time from Done. and others is clear: the White House should release the draft regulation so the DEA can move forward with finalizing a "special registration" process so Americans can continue to receive fundamental access to mental-health treatment.

About Done.
Done. is a digital health platform dedicated to empowering everyone living with attention deficit and hyperactivity disorder (ADHD) to reach their fullest potential. Through a patient-first, technology-powered ADHD treatment platform, industry-leading digital health company, Done. is making high quality psychiatric chronic care management more accessible and affordable for patients. To learn more about the platform, visit: http://www.donefirst.com.

Media Contact: [email protected]

Media Contact

Gretchen Pahia, Pitch Public Relations, 1 602-309-4286, [email protected]

SOURCE Done.

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.